Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Onivyde
Onivyde
With FDA nod for Onivyde combo, Ipsen ends 10-year drought in newly diagnosed pancreatic cancer
Fierce Pharma
Tue, 02/13/24 - 11:12 pm
Ipsen
Onivyde
Nalirifox
pancreatic cancer
FDA
Ipsen reports positive data from pancreatic ductal adenocarcinoma trial
Clinical Trials Arena
Mon, 01/23/23 - 10:53 am
Ipsen
Onivyde
metastatic pancreatic cancer
pancreatic cancer
clinical trials
PhIII fail in overall survival measure clouds Ipsen's expansion plans for cancer drug Onivyde
Endpoints
Wed, 08/3/22 - 10:51 am
Ipsen
Onivyde
small cell lung cancer
clinical trials
France's Ipsen to buy Merrimack's pancreatic cancer drug, assets in $1 bln deal
Yahoo/Reuters
Mon, 01/9/17 - 09:54 am
Ipsen
France
Merrimack Pharmaceuticals
pancreatic cancer
Onivyde
Shire bags a quick thumbs up for its newly won cancer drug pipeline
Endpoints
Mon, 07/25/16 - 11:15 am
Shire
Baxalta
M&A
Onivyde
Sales of Merrimack’s new pancreatic cancer drug top $11M in Q1
Bizjournals.com
Tue, 05/3/16 - 10:09 am
Merrimack Pharmaceuticals
Onivyde
pancreatic cancer
FDA clears Merrimack's pancreatic cancer drug with warning
Yahoo/Reuters
Thu, 10/22/15 - 07:28 pm
FDA
Merrimack Pharmaceuticals
pancreatic cancer
warnings
Onivyde